On Friday, Mylan, the Dutch generic drug making company said that speculation which says that that company may be acquired by Teva Pharmaceutical is just a rumour and it doubts whether the regulators would even approve this kind of a deal. The drug makes said that it decides to remain a stand-alone company.
Orexigen Therapeutics Inc's report which said that Contrave, its anti-obesity drug offers surprising benefits to cardiovascular patients helped the company to gain greater than thirty percent on Tuesday.
However the disclosure by the company based in Miami, made the Food and Drug Administration to ask for a second run on the cardiovascular outcomes trial.
Valeant Pharmaceuticals International Inc. to Acquire Salix Pharmaceuticals Ltd in a Cash Deal of Approximately $10.1 BillionSubmitted by Rajendra Malik on Mon, 02/23/2015 - 11:21
Wockhardt Ltd BSE 3.72 % went up to 6.2 per cent in exchange on Monday, after the pharma major said that its new medication revelation program in hostile to infective exploration and has gotten a real help after two of its medications, WCK 771 and WCK 2349, got the Qualified Infectious Disease Product (QIDP) status from the US FDA.
Walgreen the major drugstore chain of late faced pressure from the shareholders to shift overseas so as to lessen its tax bill like many other drug companies have done recently. Walgreen was earlier looking forward to become a part of a possible agreement with Alliance Boots GmbH the European drugstore chain.
- Samsung signs deal with Amazon.in to sell Galaxy K Zoom handset in India
- GE unveils smart LED light bulb – ‘Link’
- Report: iPhone 6 likely to be launched one month earlier than expected
- Huawei officially unveils its new high-end Ascend P7 smartphone
- Samsung launches its ‘Galaxy K zoom’ camera specialized-smartphone